Allspring Global Investments Holdings, LLC Intercept Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$9.99 - $18.71 $956,982 - $1.79 Million	95,794 New	95,794 $1.78 Million
Q2 2023 Jul 18, 2023	SELL	$9.17 - $19.29 $928,847 - $1.95 Million	-101,292 Reduced 53.06%	89,603 $991,000
Q1 2023 Apr 13, 2023	BUY	$12.53 - $21.71 $178,364 - $309,041	14,235 Added 8.06%	190,895 $2.56 Million
Q4 2022 Jan 23, 2023	BUY	$11.61 - $16.11 $688,728 - $955,677	59,322 Added 50.56%	176,660 $0
Q3 2022 Oct 26, 2022	BUY	$12.21 - $19.7 $127,838 - $206,259	10,470 Added 9.8%	117,338 $1.64 Million
Q2 2022 Jul 25, 2022	BUY	$11.23 - $19.59 $78,823 - $137,502	7,019 Added 7.03%	106,868 $1.48 Million
Q1 2022 May 02, 2022	BUY	$13.37 - $17.79 $154,450 - $205,510	11,552 Added 13.08%	99,849 $1.62 Million
Q4 2021 Jan 28, 2022	BUY	$14.28 - $19.53 $1.26 Million - $1.72 Million	88,297 New	88,297 $1.44 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account